Loading...

Galectin Therapeutics Inc.

GALT•NASDAQ
Healthcare
Biotechnology
$3.60
$0.30(9.09%)

Galectin Therapeutics Inc. (GALT) Stock Chart & Performance Analysis

Explore Galectin Therapeutics Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-5.15%
5-Day Change
11.21%
1-Month Change
-18.87%
3-Month Change
17.27%
6-Month Change
-50.00%
Year-to-Date (YTD) Change
10.26%
1-Year Change
-66.23%
3-Year Change
-16.23%
5-Year Change
-32.11%
All-Time (Max) Change
-89.25%

Analyzing Galectin Therapeutics Inc. (GALT) Trends Across Multiple Time Frames

Galectin Therapeutics Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Galectin Therapeutics Inc. stock shows -5.15% 1-day change, indicating low volatility, while its 5-day change of 11.21% suggests a broader trend. Over a 1-month period, a -18.87% drop could signal a pullback, whereas a 3-month rise of 17.27% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -50.00% and a YTD rise of 10.26% might concern investors, but a 1-year loss of -66.23% and a 3-year drop of -16.23% could indicate resilience. The 5-year surge of -32.11% highlights weak historical growth, while the all-time return of -89.25% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;